PK TK PK-PD Data Analysis

ICON Development Solutions has a highly-trained and experienced team of scientists with the expertise needed to glean insights from preclinical data for meaningful clinical projections. We assist sponsors to effectively transition new therapeutics from preclinical into humans, make reliable and effective early phase clinical compound assessments, and optimized clinical development strategies for achieving the fastest and most cost-effective early clinical development of their compound. 

Preclinical data analysis services including:

• Toxicokinetic data analysis
• PK data analysis
• PK/PD data analysis
• Interspecies scaling (allometry)
• Dosimetry calculations
• Bioavailability, bioequivalence data analysis
• Immunogenicity evaluation

At ICON, we use the latest industry standard software including WinNonLinTM and SASTM .